Reconstruction of single cortical projection neurons reveals primary spine loss in multiple sclerosis

Jürgens, Tanja, Jafari, Mehrnoosh, Kreutzfeldt, Mario, Bahn, Erik, Brück, Wolfgang, Kerschensteiner, Martin, Merkler, Doron·2016·Brain
DOI 10.1093/brain/awv353

Cited by (175)

Items 101–175 of 175

  1. Glial Activity Load on PET Reveals Persistent “Smoldering” Inflammation in MS Despite Disease-Modifying Treatment
    Tarun Singhal, Steven Cicero, Eero Rissanen, John Ficke, Preksha Kukreja, Steven Vaquerano, Bonnie I. Glanz, Shipra Dubey, William Sticka, Kyle Seaver et al. · 2024 · Clinical Nuclear Medicine
  2. SV2A-PET imaging uncovers cortical synapse loss in multiple sclerosis
    Emily M. Ullrich Gavilanes, Laura M. Bartos, Jonathan A. Gernert, Carla Ares Carral, Diego Ruiz Navarro, Joachim B. Havla, Lisa Ann Gerdes, Johannes S. Gnörich, Lea H. Kunze, Julia S. Dorneich et al. · 2025 · Science Translational Medicine
  3. Alterations of the axon initial segment in multiple sclerosis grey matter
    Aysegul Dilsizoglu Senol, Giulia Pinto, Maxime Beau, Vincent Guillemot, Jeffrey L. Dupree, Christine Stadelmann, Jonas Ranft, Catherine Lubetzki, Marc Davenne · 2022 · Brain Communications
  4. Complement tunes glutamate release and supports synaptic impairments in an animal model of multiple sclerosis
    Guendalina Olivero, Alice Taddeucci, Giulia Vallarino, Hanna Trebesova, Alessandra Roggeri, Maria Cristina Gagliani, Katia Cortese, Massimo Grilli, Anna Pittaluga · 2024 · British Journal of Pharmacology
  5. Immune-directed therapies in MS — efficacy and limitations
    Bernhard Hemmer, Mark Mühlau · 2017 · Nature Reviews Neurology
  6. Cuprizone as a model of myelin and axonal damage
    Stella Nyamoya, Felix Schweiger, Markus Kipp, Tanja Hochstrasser · 2017 · Drug Discovery Today Disease Models
  7. Multiple Sclerosis
    Massimo Filippi, Maria Assunta Rocca · 2020 · Springer eBooks
  8. Novel SNARE Complex Polymorphisms Associated with Multiple Sclerosis: Signs of Synaptopathy in Multiple Sclerosis
    Osman Özgür Yalın, Tuba Edgünlü, Sevim Çelik, Ufuk Emre, Taşkın Güneş, Yüksel Erdal, Aysun Ünal · 2019 · Balkan Medical Journal
  9. Decreased number and increased volume with mitochondrial enlargement of cerebellar synaptic terminals in a mouse model of chronic demyelination
    Huy Bang Nguyen, Yang Sui, Truc Quynh Thai, Kazuhiro Ikenaka, Toshiyuki Oda, Nobuhiko Ohno · 2018 · Medical Molecular Morphology
  10. Extracellular Vesicles From Multiple Sclerosis White Matter Exhibit Synaptic, Mitochondrial, Complement and Ageing‐Related Pathway Dysregulation
    Larissa Jank, Madathiparambil Kumaran Satheesh Kumar, Taekyung Ryu, Rohit Thapa, Olesia A. Gololobova, Timothy D. Niepokny, Peter A. Calabresi, Kenneth Whitaker Witwer, Ranjan Dutta, Chan Hyun Na et al. · 2025 · Journal of Extracellular Vesicles
  11. Synaptic Protein Loss in Extracellular Vesicles Reflects Brain and Retinal Atrophy in People With Multiple Sclerosis
    Dimitrios C. Ladakis, Michael P. Vreones, Joseph M. Blommer, Kimystian L. Harrison, Matthew D. Smith, Eleni S. Vasileiou, Hussein Moussa, Gelareh Ahmadi, Omar Ezzedin, Anna L. DuVal et al. · 2024 · Neurology Neuroimmunology & Neuroinflammation
  12. Oligodendrocyte and Myelin Pathophysiology in Multiple Sclerosis
    Eneritz López-Muguruza, Carla Peiró-Moreno, Asier Ruiz, Carlos Matute · 2025 · Advances in neurobiology
  13. Pathology and Pathogenesis of Progressive Multiple Sclerosis: Concepts and Controversies
    Adrian-Minh Schumacher, Christoph Friedrich Mahler, Martin Kerschensteiner · 2017 · Neurology International Open
  14. Instability of excitatory synapses in experimental autoimmune encephalomyelitis and the outcome for excitatory circuit inputs to individual cortical neurons
    Rebecca L. Gillani, Eseza N. Kironde, Sara T. Whiteman, Theodore J. Zwang, Brian J. Bacskai · 2024 · Brain Behavior and Immunity
  15. Early Synapse-Specific Alterations of Photoreceptor Mitochondria in the EAE Mouse Model of Multiple Sclerosis
    Dalia Ibrahim, Karin Schwarz, Shweta Suiwal, Sofia Maragkou, Frank Schmitz · 2025 · Cells
  16. Multiple sclerosis: what have we learned and can we still learn from electron microscopy
    Wendy Oost, Jan F. Meilof, Wia Baron · 2025 · Cellular and Molecular Life Sciences
  17. Synaptic Density in Multiple Sclerosis
    Amelie Luoma, Markus Matilainen, Jouni Tuisku, Richard Aarnio, Taru Nikkilä, Sini Laaksonen, Mikko Koivumäki, Eveliina Honkonen, Marjo Nylund, Saara Wahlroos et al. · 2025 · Neurology Neuroimmunology & Neuroinflammation
  18. Thioctamer: a novel thioctic acid–glatiramer acetate nanoconjugate expedites wound healing in diabetic rats
    Nabil A. Alhakamy, Gamal Abdallah Mohamed, Usama Ahmed Fahmy, Basma Ghazi Eid, Mohammed Wanees Al-Rabia, Amgad I. M. Khedr, Mohammed Z. Nasrullah, Sabrin R. M. Ibrahim, Ashraf B. Abdel‐Naim, Osama A. A. Ahmed et al. · 2022 · Drug Delivery
  19. Fibroblast growth factor 9 (FGF9)‐mediated neurodegeneration: Implications for progressive multiple sclerosis?
    Katja Thümmler, Claudia Wrzos, Jonas Franz, Daniel McElroy, John J Cole, Lorna Hayden, Diana Arseni, Friedrich Schwarz, Andreas Junker, Julia M. Edgar et al. · 2023 · Neuropathology and Applied Neurobiology
  20. Subventricular Zone Microstructure in Pediatric‐Onset Multiple Sclerosis
    Monica Margoni, Loredana Storelli, Elisabetta Pagani, Paolo Preziosa, Damiano Mistri, Mor Gueye, Martina Rubin, Lucia Moiola, Massimo Filippi, Maria Assunta Rocca · 2025 · Annals of Neurology
  21. Sex differences in the neuronal transcriptome and synaptic mitochondrial function in the cerebral cortex of a multiple sclerosis model
    Noriko Itoh, Yuichiro Itoh, Linsey Stiles, Rhonda R. Voskuhl · 2023 · Frontiers in Neurology
  22. That Wasn’t a Complement—Too Much C3 in Demyelinating Disease
    Wendy Xin, Jonah R. Chan · 2020 · Immunity
  23. Astroglial modulation of synaptic function in the non-demyelinated cerebellar cortex is dependent on MyD88 signaling in a model of toxic demyelination
    Melanie Lohrberg, Lena Sünke Mortensen, Carolina Thomas, Franziska Fries, Franziska van der Meer, Alexander A. Götz, Carolin Landt, Hong Jun Rhee, JeongSeop Rhee, David Gómez‐Varela et al. · 2025 · Journal of Neuroinflammation
  24. Rehabilitation on a treadmill induces plastic changes in the dendritic spines of spinal motoneurons associated with improved execution after a pharmacological injury to the motor cortex in rats
    Nallely Vázquez-Hernández, Néstor I. Martínez-Torres, Aldo Rafael Tejeda-Martínez, Mario Eduardo Flores-Soto, Hermelinda Salgado‐Ceballos, Ignacio González‐Burgos · 2022 · Journal of Chemical Neuroanatomy
  25. Antiglutamatergic therapy for multiple sclerosis?
    Reinhard Hohlfeld, Martin Kerschensteiner · 2016 · The Lancet Neurology
  26. Endogenous repair and development inspired therapy of neurodegeneration in progressive multiple sclerosis
    Ethan W. Hollingsworth, Jamil Khouri, Jaime Imitola · 2017 · Expert Review of Neurotherapeutics
  27. DCLK-1 LEVEL IN MULTIPLE SCLEROSIS PATIENTS AND ITS CORRELATION WITH CLINIC
    Fatma Şimşek, Nurinnisa Öztürk · 2020 · Multiple Sclerosis and Related Disorders
  28. Pathology of Multiple Sclerosis
    Jordon Dunham, Kedar R. Mahajan · 2021 · Springer eBooks
  29. Meningeal Lymphatic System-Driven Nanodelivery Unlocks Ursolic Acid’s Pleiotropic Benefits To Optimize Multiple Sclerosis Treatment
    Xiyu Yang, Ran Meng, Xuan Liu, Yixian Li, Tianying Wang, Ziliang Yan, Lingling Zhou, Xinyi Zhang, Peng Yang, Qizhi Zhang · 2026 · ACS Nano
  30. Glucosamine/chitosan blend surface-engineered rutin-loaded polymer/lipid hybrid nanoparticles for neuroprotection in induced schizophrenia model
    Abeer Salama, Rania Elgohary, Alaa Hamed Salama, Heba Elmotasem · 2026 · Scientific Reports
  31. Synaptic pathology in multiple sclerosis: a role for Nogo-A signaling in astrocytes?
    Sheila Espírito‐Santo, Vinícius G Coutinho, Flávia Carvalho Alcântara Gomes · 2022 · Neural Regeneration Research
  32. Dissecting brain grey and white matter microstructure: a novel clinical diffusion MRI protocol
    Simona Schiavi, Marco Palombo, Domenico Zacà, Francesco Tazza, Caterina Lapucci, Lucio Castellan, Mauro Costagli, Matilde Inglese · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  33. Biomarkers and Disease Activity in Multiple Sclerosis : A cohort study on patients with clinically isolated syndrome and relapsing remitting multiple sclerosis
    Irene Håkansson · 2019 · Linköping University medical dissertations
  34. Imaging the execution phase of neuroinflammatory disease models
    Adrian-Minh Schumacher, Thomas Misgeld, Martin Kerschensteiner, Nicolas Snaidero · 2019 · Experimental Neurology
  35. Neuroplasticity and Its Relevance for Multiple Sclerosis
    Martin Kerschensteiner · 2017 · Neurodegenerative Disease Management
  36. Immunopathogenesis
    P. Coyle · 2019 · Clinical Neuroimmunology
  37. A Review of Multiple Sclerosis as an Infectious Syndrome
    Charles W. Stratton · 2016 · Journal of Neurology & Neurophysiology
  38. Pathologie und Pathogenese der progredienten Multiplen Sklerose: Konzepte und Kontroversen
    Adrian-Minh Schumacher, Christoph Friedrich Mahler, Martin Kerschensteiner · 2017 · Aktuelle Neurologie
  39. Demyelination induces selective vulnerability of inhibitory networks in multiple sclerosis
    Lida Zoupi, Sam A. Booker, Dimitri Eigel, Carsten Werner, Peter C. Kind, Tara L. Spires‐Jones, Ben Newland, Anna Williams · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  40. Mediterranean Pattern Diet in Multiple Sclerosis: A Review Focusing on Immunometabolites
    Giulio Papiri, Cristina Paci, Giordano D’Andreamatteo, Valentina Membrino, Tiziana Di Crescenzo, Gabriella Cacchiò, Claudia Cagnetti, Arianna Vignini · 2025 · Current Neuropharmacology
  41. Silent Synapses in Multiple Sclerosis: From Synaptic Dysfunction to Reactivation‐Based Therapies—A Narrative Review of Cognitive and Neuroplasticity Outcomes
    Zinab Alatawi · 2025 · Developmental Neurobiology
  42. Pilot Study of the Total and Phosphorylated Tau Proteins in Early-Stage Multiple Sclerosis
    Ieva Navickaitė, Katryna Pampuščenko, Gintarė Žemgulytė, Diana Bilskienė, Vilmantė Borutaitė, Renata Balnytė · 2024 · Medicina
  43. The Neuropathology of Progressive Multiple Sclerosis
    Nikos Evangelou, Simon Paine, Emma Clare Tallantyre · 2017 · Springer eBooks
  44. Targeted neurotherapy: evaluating olanzapine-loaded bilosomes in a cuprizone-induced schizophrenia model
    Abeer Salama, Asmaa Badawy Darwish, Siham Mostafa Ali El-Shenawy, Marwa Anwar Wagdi · 2025 · International Journal of Pharmaceutics
  45. Development of a Human Preclinical Platform for the Identification of Neuroprotective Compounds
    Raquel Guerrero González, Elif Nur Yılmaz, Stefanie Albrecht, Maurine Fucito, Damiana Pieragostino, Alina D. Schmidt, Simone König, Una FitzGerald, Tanja Kuhlmann · 2025 · European Journal of Neuroscience
  46. Myelin Maintenance and Addition Regulate Synaptic Plasticity in the Adult Mouse Cortex
    Renee Pepper, Kalina Makowiecki, Kimberley A. Pitman, Raphael Ricci, Angela L. Nicoli, Phuong Tram Nguyen, C. Leigh Blizzard, Ben Emery, Carlie Laura Cullen, Kaylene M. Young · 2026 · Glia
  47. Immunotherapies in progressive multiple sclerosis
    Tradite Neziraj, Ludwig Kappos, Anne‐Katrin Pröbstel · 2026 · Handbook of clinical neurology
  48. Modulation of the immunological and neuroinflammatory microenvironment in older people with multiple sclerosis
    Celia Oreja‐Guevara, Sven Guenther Meuth, Nikos Grigoriadis, Patrick Vermersch, Hans Peter Hartung, Per Soelberg Sørensen, Letizia Leocani, Klaus Schmierer, Ralf Gold, O Fernandez · 2026 · Frontiers in Immunology
  49. Imaging subtypes reveal distinct biological substrates and disability profiles in multiple sclerosis
    Paolo Preziosa, Loredana Storelli, Ferdinando Clarelli, Elisabetta Pagani, Nicolò Tedone, Monica Margoni, Federica Esposito, Antonio Gallo, Alessandro d’Ambrosio, Massimo Filippi et al. · 2026 · Brain
  50. Historical review: The golden age of the Golgi method in human neuropathology
    Isidró Ferrer · 2024 · Journal of Neuropathology & Experimental Neurology
  51. The protective effect of Fingolimod upon visual behavior in a demyelination animal model is associated with synaptopathy prevention
    Ana Carolina de Pádua, Saulo Augusto Alves da Cruz, Luiza dos Santos Heringer, Greice Nascimento Pires, Daniel Areias da Silva Raquita, Jéssica dos Santos Tavares, Pedro Souto Rodrigues, Ana Cecília Dos Santos Guimarães Sá, Cíntia Monteiro de Barros, Sérgio Henrique Seabra et al. · 2025 · NeuroToxicology
  52. Immunological Tolerance Induced by Nanoliposome with Autoantigenie Peptide and Artesunate to Inhibit Complement and Remodel Immune Balance for Multiple Sclerosis Treatment
    Yaya Wei, Li Li, Tingting Fu, Ting Gao, Lanlan Ma, Wenbao Zuo, Jianhong Yang · 2025 · Advanced Healthcare Materials
  53. Unraveling cortical pathology in multiple sclerosis using the T1‐/T2‐weighted ratio?
    Caterina Mainero, Céline Louapre · 2017 · Annals of Neurology
  54. Localized calcium accumulations prime synapses for phagocyte removal in cortical neuroinflammation
    Mehrnoosh Jafari, Adrian-Minh Schumacher, Nicolas Snaidero, Tradite Neziraj, Emily M. Ullrich Gavilanes, Tanja Jürgens, Juan Daniel Flórez Weidinger, Stephanie S. Schmidt, Eduardo Beltrán, Nellwyn Hagan et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  55. Pathologie und Pathophysiologie
    Christine Stadelmann, Wolfgang Brück · 2015 · Elsevier eBooks
  56. Modulation of remyelination by adaptive inflammation and electrical stimulation
    Kunz, Patrik · 2017
  57. Much, if not all, of the cortical damage in MS can be attributed to the microglial cell – Commentary
    Jonathan I Spencer, Gabriele C. DeLuca · 2018 · Multiple Sclerosis Journal
  58. Experimental models of cortical multiple sclerosis pathology
    Maarten E. Witte, Jack van Horssen · 2017 · Drug Discovery Today Disease Models
  59. Anatomie pathologique de la sclérose en plaques et des maladies apparentées
    Danielle Seilhean, Doron Merkler · 2019 · Elsevier eBooks
  60. a Circulating cell free mitochondrial DNA copy number variation in neurodegenerative disease
    Hannah Lowes · 2018
  61. Pathophysiology of Grey Matter Affection in MS
    Gabriel González‐Escamilla, Dumitru Ciolac · 2021 · Neuromethods
  62. Literatur
    2021 · Elsevier eBooks
  63. Analysis of autoimmune lesions in grey matter
    Moritz Hermann · 2018
  64. Alterations of the axon initial segment in multiple sclerosis
    Aysegul Dilsizoglu Senol, Giulia Pinto, Maxime Beau, Vincent Guillemot, Jeffrey L. Dupree, Christine Stadelmann, Jonas Ranft, Catherine Lubetzki, Marc Davenne · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  65. Pathologie und Pathophysiologie
    Christine Stadelmann, Wolfgang Brück · 2018 · Elsevier eBooks
  66. Місце мікроглії при розсіяному склерозі: мішені та фармакологічна стратегія
    О. О. Нефьодов, O. I. Kalbus, N. P. Shastun, Л. О. Чобіток, А А Ефанова, О. П. Максименко, О. В. Широков, Валерій Степура · 2023 · Pharmacology and Drug Toxicology
  67. Glial activity load on PET (GALP) reveals persistent ‘smoldering’ inflammation in MS despite disease modifying treatment: [F-18]PBR06 study
    Tarun Singhal, Steven Cicero, Eero Rissanen, John Ficke, Preksha Kukreja, Steven Vaquerano, Bonnie I. Glanz, Shipra Dubey, William Sticka, Kyle Seaver et al. · 2023 · medRxiv
  68. Extracellular Vesicles from Multiple Sclerosis White Matter Exhibit Synaptic, Mitochondrial, Complement, and Aging-related Pathway Dysregulation
    Larissa Jank, Madathiparambil Kumaran Satheesh Kumar, Taekyung Ryu, Rohit Thapa, Olesia A. Gololobova, Timothy D. Niepokny, Peter A. Calabresi, Kenneth Whitaker Witwer, Ranjan Dutta, Chan Hyun Na et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  69. Physiopathologie de la sclérose en plaques
    Anne‐Laure Dubessy, Bruno Stankoff · 2025 · Encyclopédie médico-chirurgicale. Neurologie
  70. Additional file 1 of ISGylation is induced in neurons by demyelination driving ISG15-dependent microglial activation
    Benjamin D. S. Clarkson, Ethan M. Grund, David, Kenneth, Renee K. Johnson, Charles L. Howe · 2022 · Figshare
  71. Fisiopatologia della sclerosi multipla
    Anne‐Laure Dubessy, Bruno Stankoff · 2026 · EMC - Neurologia
  72. Rôle de la protéine C3 du système du complément dans les déficits mnésiques précoces sur un modèle expérimental de sclérose en plaques
    Julien Bourel · 2019 · theses.fr (ABES)
  73. The presynaptic protein bassoon is a biofluid biomarker of synaptic pathology in multiple sclerosis
    Marcel S. Woo, Nicola Rothammer, Lukas Can Bal, Christoph Krisp, Mario Kreutzfeldt, Susanne Witt, Aleksandra Maleska Maceski, Bente Siebels, Lukas Raich, Christina Mayer et al. · 2026 · EBioMedicine
  74. Microglia in multiple sclerosis: pathogenesis and therapeutic modulation
    I. Nazarova, D. Nazarova, Y.P. Barbashova · 2026 · Georgian Medical Journal
  75. Cerebrospinal fluid amino acid alterations are associated with oxidative stress and neuronal injury markers in multiple sclerosis
    Radka Bartová, Darina Slezáková, Monika Ďurfinová · 2026 · Metabolic Brain Disease